全文获取类型
收费全文 | 399篇 |
免费 | 31篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 16篇 |
妇产科学 | 3篇 |
基础医学 | 39篇 |
口腔科学 | 5篇 |
临床医学 | 81篇 |
内科学 | 116篇 |
皮肤病学 | 6篇 |
神经病学 | 6篇 |
特种医学 | 26篇 |
外科学 | 52篇 |
综合类 | 23篇 |
眼科学 | 13篇 |
药学 | 78篇 |
中国医学 | 1篇 |
肿瘤学 | 48篇 |
出版年
2023年 | 1篇 |
2022年 | 3篇 |
2021年 | 9篇 |
2020年 | 11篇 |
2019年 | 12篇 |
2018年 | 7篇 |
2017年 | 8篇 |
2016年 | 12篇 |
2015年 | 5篇 |
2014年 | 12篇 |
2013年 | 20篇 |
2012年 | 15篇 |
2011年 | 16篇 |
2010年 | 18篇 |
2009年 | 14篇 |
2008年 | 18篇 |
2007年 | 72篇 |
2006年 | 19篇 |
2005年 | 28篇 |
2004年 | 12篇 |
2003年 | 11篇 |
2002年 | 11篇 |
2001年 | 17篇 |
2000年 | 8篇 |
1999年 | 11篇 |
1998年 | 24篇 |
1997年 | 17篇 |
1996年 | 19篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 10篇 |
1992年 | 8篇 |
1991年 | 10篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有516条查询结果,搜索用时 0 毫秒
511.
Sinha S Gastineau D Micallef I Hogan W Ansell S Buadi F Dingli D Dispenzieri A Gertz M Greiner C Hayman S Inwards D Johnston P Lacy M Litzow M Porrata L Winters JL Kumar S 《Bone marrow transplantation》2011,46(7):943-949
PBSCs are usually mobilized using G-CSF with or without chemotherapy. With the emergence of newer mobilizing agents, predicting poor mobilization may allow early intervention and prevent the costs and complications associated with remobilization. We retrospectively evaluated a cohort of 1556 patients seen between January 2000 and September 2008 with multiple myeloma (565; 36%), non-Hodgkin's lymphoma (NHL) (562; 36%), amyloidosis (345; 22%) or Hodgkin's disease (94; 6%), who were initially mobilized with single agent G-CSF. Sensitivity and specificity analysis was used to identify ideal peripheral blood CD34 count (PB-CD34) cutoff points that predicted successful collection. In patients with plasma cell disorders, a PB-CD34 count of 11, 17, 21 and 28/μL by day 4 or 5 was required to collect a target of 2, 4, 8 or 12 million cells/kg, respectively. A CD34 yield of <0.8 million cells/kg on first apheresis also predicted for <2 million CD34 cells/kg. For patients with NHL or Hodgkin's disease, a PB-CD34 count of <6 and <15/μL on day 4 or 5 predicted failure to achieve a target collection of 2 and 4 million cells/kg, respectively. This study suggests that PB-CD34 thresholds should be based on collection target to allow for early intervention and to prevent collection failures. 相似文献
512.
513.
514.
Peng R; Al-Katib A; Knowles DM d; Lu L; Broxmeyer H; Tolidjian B; Chiao JW; Koziner B; Wang CY 《Blood》1984,64(6):1169-1178
A series of monoclonal antibodies recognizing myeloid differentiation antigens were prepared by immunizing Balb/c mice with HL-60 cells. Hybrids secreting antibodies reactive with HL-60 cells but unreactive with peripheral blood mononuclear cells were isolated and further cloned. One clone was found to produce an IgG2a antibody recognizing an 85,000-dalton molecular weight surface glycoprotein, and a second clone was found to produce an IgM antibody recognizing a heat-stable determinant present on a glycolipid. We have termed these antigens Pro- Im1 and Pro-Im2, respectively (Pro for using HL-60 promyelocytes as an immunogen and Im for the presence of these antigens on immature cells). alpha Pro-Im1 and alpha Pro-Im2 were used to investigate the surface expression and tissue distribution of these two antigens. Pro-Im1 and Pro-Im2 were found to be brightly expressed on a fraction of fetal liver hematopoietic and bone marrow cells. Both antibodies mediated complement-dependent inhibition of CFU-GM, BFU-E, and CFU-GEMM formation assayed by soft agar colony and burst formation, indicating the expression of these antigens by early hematopoietic precursor cells. This was further confirmed by the induction of HL-60 cells by TPA to differentiate into more mature monocytes and macrophages, accompanied by the loss of both antigens. Pro-Im1 and Pro-Im2 were absent from peripheral blood monocytes, erythrocytes, and platelets, but Pro-Im2 was expressed on granulocytes. Both antigens were absent from thymocytes and peripheral T cells. Cytofluorographic analysis suggested their absence from peripheral blood B cells but that both were expressed on a minority of tissue B cells. Analysis of 150 cases of various myeloid and lymphoid malignancies demonstrated Pro-Im1 and Pro-Im2 expression on myeloblasts and promyelocytes from some acute myelogenous leukemias as well as some B cell malignancies, suggesting that these antigens are shared by early hematopoietic cells and a subset of B cells. 相似文献
515.
Lin Li Jing Wang Cheng-Cheng Tong Chi-Yi He 《Hepatobiliary & pancreatic diseases international : HBPD INT》2023,22(3):282-287
Background: The risk factors for the recurrent choledocholithiasis after endoscopic retrograde cholangiopancreatography(ERCP) have not been well studied. The aim of this study was to explore the risk factors of recurrent choledocholithiasis. Methods: We carried out a retrospective analysis of data collected between January 1, 2010 and January 1, 2020. Univariate analysis and multivariate analysis were used to explore the independent risk factors of recurrent choledocholithiasis following therape... 相似文献
516.